Business Context and Reporting Period
This Form 8-K Current Report was filed by Protara Therapeutics, Inc. on June 20, 2022, with the earliest event reported on June 21, 2022. The filing discloses the departure of a senior executive and the terms of their separation agreement.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and separation terms.
Material Changes
The primary material change reported is the resignation of Blaine Davis, Chief Financial Officer, effective July 15, 2022. The filing states the resignation was not the result of any disagreement regarding the Company's operations, policies, or practices.
Guidance, Outlook, and Separation Terms
Management commentary is limited to the announcement of the CFO's departure. The filing details a Separation Agreement and Release dated June 20, 2022, which includes the following compensation terms for Mr. Davis:
- Base salary for a period of twelve months, paid in a lump sum.
- A one-time lump sum payment of his bonus at target.
- Reimbursement of all business expenses.
- Reimbursement of COBRA premium costs for twelve months.
- Reimbursement of supplemental life insurance premium costs for twelve months.
- Pro rata vesting of outstanding option award grants.
- Full vesting of restricted stock unit award grants.
The filing includes standard forward-looking statement disclaimers, noting that actual results may differ materially from anticipated results due to various risks.
Investor Verification Checklist
- Verify the appointment of an interim or permanent replacement for the Chief Financial Officer.
- Review the full text of the Separation Agreement (Exhibit 10.1) for additional covenants or non-compete clauses.
- Assess the impact of the CFO departure on the Company's ongoing financial reporting and strategic execution.
- Check subsequent filings for any changes in the Company's liquidity position or capital raise activities following this announcement.